DIATHEVA presented a new product in pipeline “scFv 2G8” at BIO CONVENTION 2016 in the context of a workshop dedicated to showcasing of novel antibiotics which was held the past 6 June in San Francisco. Hosted by the Innovative Medicines’ Initiative (IMI), The Wellcome Trust-funded Community For Open Antimicrobial Drug Discovery and the IMI funded ENABLE project, the workshop was aimed to highlight the global tools available to support the development of novel anti-infectives coming from10 innovative company programmes from six countries.